BIOFOX brings technology, education, and marketing together, drawing on 20 years of practical experience in the aesthetics industry. Signature Magazine met DERMANOVA CEO Cho Ye na, whose EGF solutions and MICROJET system have reached approximately 500 specialist locations nationwide.
Question.
How did the career in aesthetics begin, and how has it developed?
I worked as an esthetic clinic owner for 20 years and experienced the practical challenges other owners face. My clinic achieved notable results and attracted clients from distant areas. That experience taught me that good techniques and products alone do not necessarily generate sales. Consultation, repeat visits, package sales, staff education, and marketing must work together. I wanted to build a brand offering practical education and systems alongside products. DERMANOVA now develops skin conditioning protocols and business growth systems around BIOFOX and MICROJET, connecting treatment outcomes with revenue.
Question.
DERMANOVA recently announced its 500th specialist location in Korea and overseas. Which capabilities and programs have supported this expansion?
The aesthetics market is at a turning point. Earlier treatments focused on manual techniques and topical cosmetics. The industry is moving toward precise protocols informed by skin structure, responses, client age, and skin condition. Conventional approaches may not adequately address clients from their mid forties with slower skin regeneration, compromised skin barriers after repeated procedures, or increasing aging concerns. Stronger stimulation alone is not the answer. The approach requires gentle technologies, care designed for weakened skin barriers, and care signaling intended to support recovery of skin condition.
POINT 1
The 10 GF Complex and Its Role in Skin Recovery
BIOFOX’s growth factor complex, 10-GF, is central to this approach. We describe it as a proprietary complex combining eight active FGF types, EGF, and ten peptides with structures and activity matching human factors. The company presents it as the only activated complex of its kind in Korea. BIOFOX 10-GF MICROJET Booster attaches to the MICROJET device and forms a core part of its protocol. Its technology formulates peptides matching endogenous factors into proteins intended to remain stable in liquid form at room temperature. The sterile, preservative free product requires immediate use after opening, making freshness important. Its growth factors are intended for absorption as part of skin tissue care and skin barrier conditioning.
POINT 2
Cheonbang Care Combining Growth Factors and Skin Resilience
Cheonbang Care combines MICROJET’s precise, gentle treatment with the BIOFOX 10-GF solution. It is a core treatment attracting substantial interest among clinic owners. MICROJET combines laser, air booster, and multi ultrasound functions in one device. It is described as creating approximately 100 uniform micro holes in the epidermis per shot to increase solution absorption. Depending on skin type, protocols may involve up to 1,000 shots and aim to support active ingredient absorption across multiple layers. Rather than imposing excessive stimulation, the protocol uses a low irritation laser to prepare the absorption environment. BIOFOX 10-GF Booster then supports a skin conditioning approach.
DERMANOVA connects EGF based solutions with practical protocols for esthetic clinics. Ingredient recognition alone matters less in practice than selecting ingredients, planning delivery and absorption, explaining the process, and supporting repeat visits and package sales. Our 10-GF protocols with MICROJET help clinic owners provide clear explanations and treatment experiences clients can perceive.
POINT 3
Reaju and Microcurrent Technology
Reaju is an EMS microcurrent device informed by Eastern medicine and the proposed cellular recovery effects of microcurrent. It is designed for relaxation without disrupting autonomic balance, rather than strong stimulation. Adjustable intensity and an emphasis on whole body circulation underpin its approach to physical balance. Its proposed mechanism addresses circulation and accumulated waste clearance, with the aim of creating visibly firmer face and body contours. In practice, we have observed greater synergy when it is combined with stretching.
Question.
Which products complement 10-GF and Cheonbang Care most closely?
BIOFOX 10-GF Reverse Aging Cure Booster follows EGF based Cheonbang Care and completes the program. We describe its technology as sufficiently established for distribution as a medical device. It is also used in cases where recovery is slow. The newly launched Medipress line covers care before and after procedures. It includes pre treatment cleansing and laser toner, immediate post procedure repair cream, UV care, daily care, and emergency heat care. It was developed to reduce variation between practitioners and support consistent treatment results. Additional Medipress products are scheduled for phased release this year.
Question.
How does DERMANOVA organize education connecting technology, practice, and marketing?
Esthetician education connects technology, consultation, marketing, and operations rather than covering products alone. Technical sessions every Wednesday explain EGF, BIOFOX’s core ingredient, and its proposed mechanisms. Professional training takes place on the first Tuesday of each month. Six clinic owners recognized as key opinion leaders, or KOLs, lead the sessions based on their experience using BIOFOX. New specialist clinic owners receive individual mentoring that considers MBTI profiles, personal tendencies, and concerns involving consultation, marketing, or treatment. They are then matched with a suitable KOL mentor. Director Shim Gyeong hui also leads MICROJET product and practical training every two weeks. Zoom sessions give owners with limited access opportunities to learn regardless of location.
Question.
How does the AI application Patfoxy incorporate 20 years of experience?
Our proprietary AI application, Patfoxy, is central to DERMANOVA’s education system. It goes beyond a resource library. An AI harness trained on my 20 years of experience brings consultation, education, and marketing into one platform. Consultation content incorporates techniques I used in practice, allowing clinic owners to follow structured examples. Role playing videos cover devices, skin types, cosmetics, and consultations involving melasma and pigmentation, with each chapter lasting five minutes. The education section gathers all materials needed for BIOFOX and MICROJET so practical workflows can be learned through the application. It also provides menus, an online design store, event banners, post procedure precautions, and product images for daily operations. Marketing is its most distinctive feature. Owners enter client age, skin concerns, and treatment details, and AI generates content for Instagram and blogs. This allows AI to handle content planning and writing as a marketing assistant. Patfoxy helps owners use headquarters’ knowledge and systems without managing everything alone, with the aim of supporting stable revenue.
Question.
How should BIOFOX be remembered, and what are the next goals?
I hope BIOFOX is remembered for changing standards in skin conditioning, beyond being a cosmetics brand. I believe understanding and using EGF skincare solutions will become essential for estheticians. Together with MICROJET, we aim to standardize gentle protocols for clients experiencing declining skin condition from their mid forties. Education, marketing, and AI based operations will support an ecosystem in which clinic owners can grow. Our target for the coming year is 1,000 specialist locations in Korea. We also plan to strengthen operations around staff with a sound understanding of mechanisms. KOL and supervisor education will be reorganized to improve training quality further.
Product development is also continuing. A Lacto PDRN line and sheet masks are planned, alongside expansion into the hospital market. The medical clinic care line launched last June adds FGF ingredients to the existing Cheonbang Care solution, aiming to complement EGF. It was developed following inquiries from medical clinics. Subject to authorization in July, we also plan another laser device designed for faster treatment at greater depth than MICROJET. For marketing, we completed a shoot with actress Song Sun mi. Content distribution from June through August will precede a formal September launch and a second marketing campaign.
Our longer term goal is to replicate Korea’s education, protocol, and marketing systems internationally and establish new standards in the global aesthetics market.
Editor GAHEE, BAEK
Image Shutterstock
The Signature Magazine – July 2026 Issue